Allergan Inc.'s Botox Cosmetic As Actavis Plc Buys Drugmaker For $66 Billion

A clinical technician holds a box of Allergan Botox, produced by Allergan Inc., in this arranged photograph taken at a skin and beauty clinic in London, U.K., on Monday, Nov. 17, 2014. Actavis Plc agreed to pay about $66 billion for Allergan, a deal that creates a new top 10 drugmaker and ends Valeant Pharmaceuticals International Inc.'s attempt at a hostile takeover of the maker of Botox. Photographer: Jason Alden/Bloomberg via Getty Images
A clinical technician holds a box of Allergan Botox, produced by Allergan Inc., in this arranged photograph taken at a skin and beauty clinic in London, U.K., on Monday, Nov. 17, 2014. Actavis Plc agreed to pay about $66 billion for Allergan, a deal that creates a new top 10 drugmaker and ends Valeant Pharmaceuticals International Inc.'s attempt at a hostile takeover of the maker of Botox. Photographer: Jason Alden/Bloomberg via Getty Images
Allergan Inc.'s Botox Cosmetic As Actavis Plc Buys Drugmaker For $66 Billion
LICENTIE KOPEN
Hoe mag ik dit beeld gebruiken?
€ 475,00
EUR

GEGEVENS

Beperkingen:
Neem voor gebruik voor alle commerciële of promotiedoeleinden contact op met uw lokale kantoor.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Credits:
Bloomberg / Contributor
Redactioneel nr.:
459119630
Collectie:
Bloomberg
Gemaakt op:
17 november 2014
Datum van uploaden:
Soort licentie:
Release-informatie:
Geen release. Meer informatie
Bron:
Bloomberg
Naam materiaal:
UK ALLERGAN ACTAVIS
Max. bestandsgrootte:
2666 x 4000 px (22,57 x 33,87 cm) - 300 dpi - 2 MB